Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zicam Cough Mist is an over-the-counter antitussive medication used for the temporary relief of coughs caused by minor throat and bronchial irritation, such as those associated with the common cold or inhaled irritants. The active ingredient is dextromethorphan hydrobromide, a non-opioid morphinan derivative that acts centrally on the cough center in the medulla oblongata. By elevating the cough threshold, it effectively suppresses the urge to cough without providing significant analgesic or sedative effects at therapeutic doses. Unlike many other products under the Zicam brand that are marketed as homeopathic cold remedies, Zicam Cough Mist is a conventional pharmaceutical formulation. It is typically administered as an oral spray, providing a convenient delivery method for immediate-release cough suppression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zicam Cough Mist.